Thymoglobulin: Phase II data

Data from an open-label, U.S. and European Phase II trial in 278 patients undergoing

Read the full 149 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE